07:00 , Oct 22, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: CD93 (C1QR)

Cancer INDICATION: Acute myelogenous leukemia (AML) Mouse and cell studies suggest inhibiting CD93 could help treat mixed-lineage leukemia (MLL)-rearranged acute myeloid leukemia (AML). Human MLL-rearranged AML cells had higher levels of CD93 than non-MLL-rearranged leukemia...
08:00 , Nov 14, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Pain CD93 (C1QR); VGF nerve growth factor inducible (VGF) In vitro and rat studies suggest inhibiting C1QR could help treat neuropathic pain. VGF and the...